KLK3 and posterior cortical atrophy: The largest published cohort of 200 retrospectively analyzed patients with non-metastatic hormone-resistant PCa and a PSA serum level > 2 ng/ml by Fendler et al. reported a detection rate of 98%, and 55% of the patients with M1 disease [20].